Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Stakeholders
2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Instruments
2.1.1.1. Secondary Instrument
2.1.1.2. Primary Instrument
2.1.2. Research Approaches
2.1.2.1. Bottom-up Approach
2.1.2.2. Top-down Approach
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.1.5. Vendor Inclusion Criteria
2.2. Forecasting Methodology
2.2.1. Methodology for Market Estimation & Forecasting
2.2.2. Significance and Importance of the Market Estimation & Forecasting
3. Executive Summary
4. Premium Insight
4.1. Market Connectivity
4.2. Market Data Feed
4.3. Market Vendor Ranking Analysis
4.4. Market Dynamics
4.4.1. Drivers
4.4.1.1. Increased focus on human microbiome therapy
4.4.1.2. Human microbiome for drug development, early disease detection, and diagnosis
4.4.2. Restraints
4.4.2.1. Limited expertise and lack of comprehensive research
4.4.3. Opportunities
4.4.3.1. Increasing collaborations and research investments to create growth opportunities
4.4.3.2. Development of human microbiome therapeutic products
4.4.4. Challenges
4.4.4.1. Causal links between microbiota dysbiosis and disease
4.5. Porter's Five Forces Analysis
4.5.1. Threat of New Entrants
4.5.2. Threat of Substitutes
4.5.3. Bargaining Power of Customers
4.5.4. Bargaining Power of Suppliers
4.5.5. Industry Rivalry
4.6. Regulatory Framework
4.7. Patent & Funding
4.8. Impact of Human Microbiome Therapeutics on Current Treatment Options
5. Global Human Microbiome Market, by Disease
5.1. Introduction
5.2. Acute Diarrhea
5.3. Autoimmune Disorders
5.4. Cancer
5.5. Diabetes
5.6. Mental Disorders
5.7. Obesity
6. Global Human Microbiome Market, by Product
6.1. Introduction
6.2. Diagnostic Devices
6.3. Drugs
6.4. Foods
6.5. Medical Foods
6.6. Prebiotics
6.7. Probiotics
7. Global Human Microbiome Market, by Technology
7.1. Introduction
7.2. 16s rRNA Sequencing
7.3. Cell Culture Technology
7.4. Computational Tools
7.5. High-Throughput Technology
7.6. Metagenomic Sequencing
7.7. Omics Technology
8. Global Human Microbiome Market, by Theuraptic Area
8.1. Introduction
8.2. Gastrointestinal Disorders
8.3. Metabolic Disorders
8.4. Skin Disorders
8.5. Women's Health
9. Global Human Microbiome Market, by Application
9.1. Introduction
9.2. Diagnostics
9.3. Therapeutics
10. Global Human Microbiome Market, by Geography
10.1. Introduction
10.2. Americas Human Microbiome Market
10.2.1. Americas Human Microbiome Market, by Country
10.2.1.1. United States
10.2.1.2. Brazil
10.2.1.3. Canada
10.2.1.4. Mexico
10.2.1.5. Argentina
10.2.2. Americas Human Microbiome Market, by Disease
10.2.3. Americas Human Microbiome Market, by Product
10.2.4. Americas Human Microbiome Market, by Technology
10.2.5. Americas Human Microbiome Market, by Theuraptic Area
10.2.6. Americas Human Microbiome Market, by Application
10.3. Europe, Middle East & Africa Human Microbiome Market
10.3.1. Europe, Middle East & Africa Human Microbiome Market, by Country
10.3.1.1. United Kingdom
10.3.1.2. Germany
10.3.1.3. France
10.3.1.4. Saudi Arabia
10.3.1.5. United Arab Emirates
10.3.1.6. Italy
10.3.1.7. Russia
10.3.2. Europe, Middle East & Africa Human Microbiome Market, by Disease
10.3.3. Europe, Middle East & Africa Human Microbiome Market, by Product
10.3.4. Europe, Middle East & Africa Human Microbiome Market, by Technology
10.3.5. Europe, Middle East & Africa Human Microbiome Market, by Theuraptic Area
10.3.6. Europe, Middle East & Africa Human Microbiome Market, by Application
10.4. Asia-Pacific Human Microbiome Market
10.4.1. Asia-Pacific Human Microbiome Market, by Country
10.4.1.1. China
10.4.1.2. Japan
10.4.1.3. India
10.4.1.4. Australia
10.4.2. Asia-Pacific Human Microbiome Market, by Disease
10.4.3. Asia-Pacific Human Microbiome Market, by Product
10.4.4. Asia-Pacific Human Microbiome Market, by Technology
10.4.5. Asia-Pacific Human Microbiome Market, by Theuraptic Area
10.4.6. Asia-Pacific Human Microbiome Market, by Application
11. 360iResearch Competitive Strategic Window
11.1. Introduction
11.1.1. Leverage Zone
11.1.2. Vantage Zone
11.1.3. Speculative Zone
11.1.4. Bottleneck Zone
12. 360iResearch FPNV Positioning Matrix
12.1. Introduction
12.2. 360iResearch Scores
12.2.1. Forefront
12.2.2. Pathfinders
12.2.3. Niche
12.2.4. Vital
12.3. Business Strategy
12.4. Product Satisfaction
13. Competitive News Feed Analysis
14. Company Usability Profiles
14.1. DuPont
14.2. E.I. Du Pont De Nemours and Company
14.3. Enterome Bioscience
14.4. Merck & Co., Inc.
14.5. Metabiomics Corporation
14.6. Microbiome Therapeutics, LLC
14.7. Osel, Inc.
14.8. Second Genome, Inc.
14.9. Seres Therapeutics
14.10. Synthetic Biologics Inc.
14.11. Vedanta Biosciences, Inc.
14.12. Vithera Pharmaceuticals
14.13. Yakult Honsha Co., Ltd.
15. Appendix
15.1. Top Reports
15.2. Author Details

LIST OF TABLES (56 TABLES)

TABLE 1. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 2. GLOBAL HUMAN MICROBIOME MARKET RANKING, BY VENDORS, 2017
TABLE 3. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2016 - 2024 (USD MILLION)
TABLE 4. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 5. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 6. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CANCER, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 7. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIABETES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 8. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 9. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OBESITY, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 10. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2016 - 2024 (USD MILLION)
TABLE 11. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 12. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DRUGS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 13. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY FOODS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 14. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MEDICAL FOODS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 15. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 16. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 17. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2016 - 2024 (USD MILLION)
TABLE 18. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 19. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 20. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 21. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 22. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 23. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 24. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THEURAPTIC AREA, 2016 - 2024 (USD MILLION)
TABLE 25. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 26. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 27. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 28. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY WOMEN'S HEALTH, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 29. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD MILLION)
TABLE 30. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 31. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 32. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 33. AMERICAS HUMAN MICROBIOME MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 34. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2016 - 2024 (USD MILLION)
TABLE 35. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2016 - 2024 (USD MILLION)
TABLE 36. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2016 - 2024 (USD MILLION)
TABLE 37. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY THEURAPTIC AREA, 2016 - 2024 (USD MILLION)
TABLE 38. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD MILLION)
TABLE 39. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 40. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2016 - 2024 (USD MILLION)
TABLE 41. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2016 - 2024 (USD MILLION)
TABLE 42. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2016 - 2024 (USD MILLION)
TABLE 43. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY THEURAPTIC AREA, 2016 - 2024 (USD MILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD MILLION)
TABLE 45. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 46. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2016 - 2024 (USD MILLION)
TABLE 47. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2016 - 2024 (USD MILLION)
TABLE 48. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2016 - 2024 (USD MILLION)
TABLE 49. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY THEURAPTIC AREA, 2016 - 2024 (USD MILLION)
TABLE 50. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD MILLION)
TABLE 51. 360IRESEARCH SCORES FOR FOREFRONT IN HUMAN MICROBIOME MARKET
TABLE 52. 360IRESEARCH SCORES FOR PATHFINDERS IN HUMAN MICROBIOME MARKET
TABLE 53. 360IRESEARCH SCORES FOR NICHE IN HUMAN MICROBIOME MARKET
TABLE 54. 360IRESEARCH SCORES FOR VITAL IN HUMAN MICROBIOME MARKET
TABLE 55. 360IRESEARCH FPNV POSITIONING MATRIX BUSINESS STRATEGY FOR HUMAN MICROBIOME MARKET
TABLE 56. 360IRESEARCH FPNV POSITIONING MATRIX PRODUCT SATISFACTION FOR HUMAN MICROBIOME MARKET

LIST OF FIGURES (48 TABLES)

FIGURE 1. GLOBAL HUMAN MICROBIOME MARKET: YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL HUMAN MICROBIOME MARKET: KEY RESEARCH METHODOLOGY
FIGURE 3. GLOBAL HUMAN MICROBIOME MARKET: KEY RESEARCH INSTRUMENTS
FIGURE 4. GLOBAL HUMAN MICROBIOME MARKET: KEY SECONDARY INSTRUMENT SOURCES
FIGURE 5. GLOBAL HUMAN MICROBIOME MARKET: KEY POTENTIAL RESPONDENTS
FIGURE 6. GLOBAL HUMAN MICROBIOME MARKET: KEY BREAKDOWN OF PRIMARY INSTRUMENT
FIGURE 7. GLOBAL HUMAN MICROBIOME MARKET: KEY RESEARCH APPROACHES
FIGURE 8. GLOBAL HUMAN MICROBIOME MARKET: KEY DATA TRIANGULATION
FIGURE 9. GLOBAL HUMAN MICROBIOME MARKET: KEY RESEARCH ASSUMPTIONS
FIGURE 10. HUMAN MICROBIOME MARKET: KEY MARKET CONNECTIVITY
FIGURE 11. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2016 - 2024 (USD MILLION)
FIGURE 12. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017 VS 2024 (USD MILLION)
FIGURE 13. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 14. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 15. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CANCER, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 16. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIABETES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 17. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 18. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OBESITY, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 19. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017 VS 2024 (USD MILLION)
FIGURE 20. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 21. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DRUGS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 22. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY FOODS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 23. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MEDICAL FOODS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 24. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 25. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 26. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017 VS 2024 (USD MILLION)
FIGURE 27. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 28. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 29. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 30. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 31. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 32. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 33. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THEURAPTIC AREA, 2017 VS 2024 (USD MILLION)
FIGURE 34. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 35. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 36. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 37. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY WOMEN'S HEALTH, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 38. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017 VS 2024 (USD MILLION)
FIGURE 39. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 40. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 41. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 42. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET, BY DISEASE, 2024
FIGURE 43. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET, BY PRODUCT, 2024
FIGURE 44. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET, BY TECHNOLOGY, 2024
FIGURE 45. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET, BY THEURAPTIC AREA, 2024
FIGURE 46. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET, BY APPLICATION, 2024
FIGURE 47. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET, BY GEOGRAPHY, 2024
FIGURE 48. 360IRESEARCH FPNV POSITIONING MATRIX FOR HUMAN MICROBIOME MARKET